News
Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate Praxis Precision Medicines' ulixacaltamide study for essential tremor faces setback as IDMC ...
SciSparc Ltd (NASDAQ:SPRC) shares are ripping higher Monday after the company announced that its collaboration with Clearmind Medicine Inc (NASDAQ:CMND) led to a patent application for psychedelic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback